PerioTrap
Halle (Saale), DE · 5 known investors
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.
Founders & leadership
Investors · 5
Biotech Investments S.R.OPrague
CompanistoBerlin · $275K – $8.8M
bmp Venturesreported · 2 sourcesBerlin · $550K – $16.5M
Also in the syndicate · 2
Fraunhofer Venturei&i Prague
In the news
2,9 Mio. EUR für PerioTrapbmp.com · Mar 2026
PerioTrap raises €2.7 million with private investor supportbmp.com · Feb 2025
PerioTrap Pharmaceuticals raises €3M seed round to develop selective anti-infectives to tackle periodontitis - bmp Ventures AGbmp.com · Oct 2020Frequently asked questions
- What does PerioTrap do?
- PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.
- Who are PerioTrap's investors?
- PerioTrap's investors include Biotech Investments S.R.O, Companisto, bmp Ventures.
- Where is PerioTrap headquartered?
- PerioTrap is headquartered in Halle (Saale), DE.